Synkrino Biotherapeutics Company

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients.
Technology: Data-driven Technologies
Industry: Artificial Intelligence, Biotechnology, Early Drug Development, Health Care, PharmTech, Therapeutics, United States
Headquarters: Berkeley, California, United States
Founded Date: 2018-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Estimated Revenue: Less than $1M
Last Funding Date: 2018-08-23
Last Funding Type: Seed

Visit Website
Register and Claim Ownership